Here, for the first time, we present evidence that CPX dose-dependently inhibits cell proliferation and induces apoptotic cell death in NSCLC cells (A549 and A427), which could be potentiated by the addition of PRE, a Chk1 inhibitor. This evidence concerns the gene CHEK1 and non-small cell lung carcinoma.